Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 长江润发健康产业股份有限公司系中国民营企业500强长江润发集团有限公司下属子公司,成立于1999年,总部位于江苏省张家港市“全国文明村”长江村,2010年在深交所挂牌上市(股票简称:长江健康股票代码:002435)。 一直以来,公司始终坚持“创业一艰苦奋斗、成功一八方相助、信誉一效益之本、发展一永不自满”的企业宗旨,现已发展成为拥有多家子公司的集团型企业,行业涵盖医药制造、医疗服务等领域,形成了以“医药+医疗”双轮驱动、健康发展的战略格局。 自2015年以来,公司围绕妇女儿童的健康事业,积极对接“健康中国”战略,加快转型步伐,先后收购了以医药制造、研发为代表的海灵药业、海南新合赛制药;以原料生产为代表的上海益威、湖南三清药业;以妇产专科服务为代表的郑州圣玛妇产医院、郑州东方女子医院等五家优质专科医院;以中药制造为代表的山东华信制药,成立以医药科技研发为主体的苏州研发中心,投资建设无锡怡和妇产专科医院,为妇女)L童提供零到百岁全方位全周期的健康服务,从全面小康迈向全方位健康。 | ||||||||||||||||||||||||
Main Business | 主要从事医药产品研发、生产和销售,提供妇产科专科医疗服务,以及电梯导轨等机械产品的销售。 | ||||||||||||||||||||||||
Legal Representative | 黄忠和 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 孙文遥 | ||||||||||||||||||||||||
Solicitors | 北京市金杜律师事务所 | ||||||||||||||||||||||||
Auditors | 信永中和会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0512-56926898 | ||||||||||||||||||||||||
Fax No | 0512-56926898 | ||||||||||||||||||||||||
Website | cjjkcy.com | ||||||||||||||||||||||||
swynet@126.com;xiaguoxing_seven@126.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 18/06/2010 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ -0.620 | ||||||||||||||||||||||||
DPS(RMB)* | -- | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 3.018 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 1.227B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |